Executive Summary
NASA allocated $332.7M across two neutral R&D contracts to California nonprofit universities for SPHEREX all-sky survey ($267.7M, 96% outlayed) and ESCAPADE Mars plasma mission Phase A ($65M, 82% outlayed), underscoring stable federal funding through 2028. No direct public equity impacts due to nonprofit recipients, but signals consistent NASA commitment to foundational space science. Extended timelines highlight execution risks amid potential budget shifts.
Tracking the trend? Catch up on the prior NASA & Space Contracts Intelligence digest from January 13, 2026.
Risk Flags(1)
- Execution[MEDIUM RISK]▼
Extended performance to 2026-02-28 (ESCAPADE) and 2028-04-30 (SPHEREX) exposes contracts to program delays, funding cuts, or parent task order dependency.
Opportunities(1)
- ◆
$5.2M unexercised options ($5.1M SPHEREX + $0.13M ESCAPADE) plus potential ESCAPADE Phase B follow-on.
Sector Themes(1)
- ◆
Both contracts (100% of period's value) to CA nonprofits (Caltech, UC Regents) under NAICS 541715 for cost-reimbursable space science.
Watch List(2)
- 👁
{"entity"=>"ESCAPADE mission", "reason"=>"Phase A ends 2026-02-28 with $11.6M remaining; gateway to full mission funding.", "trigger"=>"Phase B award or NASA announcement"}
- 👁
{"entity"=>"SPHEREX mission", "reason"=>"$13.2M remaining to 2028-04-30 under delivery order structure.", "trigger"=>"Option exercise or JPL funding updates"}
Get daily alerts with 1 risk alerts, 1 opportunities and full AI analysis of all 2 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC